tetano
Editor, Senior Moderator
J Clin Med
. 2025 Mar 8;14(6):1823.
doi: 10.3390/jcm14061823. Long-Term Evolution of Post-COVID-19 Echocardiographic Parameters in Patients with Chronic Kidney Disease: A Prospective Comparative Observational Study
Laura Vasiliu[SUP] 1 2 [/SUP], Anca Diaconu[SUP] 2 [/SUP], Mihai Onofriescu[SUP] 1 [/SUP], Gianina Dodi[SUP] 1 [/SUP], Alexandra Covic[SUP] 1 2 [/SUP], Alexandra E Avanu[SUP] 1 [/SUP], Luminita Voroneanu[SUP] 1 [/SUP], Vlad Vasiliu[SUP] 1 [/SUP], Mehmet Kanbay[SUP] 3 [/SUP], Radu A Sascău[SUP] 1 2 [/SUP], Cristian Stătescu[SUP] 1 2 [/SUP], Adrian C Covic[SUP] 1 4 5 [/SUP]
Affiliations
Background/Objectives: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused post-acute sequelae, especially for people with pre-existing conditions, including chronic kidney disease (CKD), which may impact the cardiovascular system. Yet, despite the preliminary description of the general population's long-COVID-19 consequences, data on CKD patients is scarce. The aim of this study was to investigate the longitudinal effects of COVID-19 on echocardiographic parameters of cardiac function and on cardiac biomarkers in patients with CKD. Methods: A total of 163 patients were included in this observational prospective trial (listed under NCT05125913 code): 88 in the COVID-19 group and 75 in the control group. The serial echocardiographic characteristics in patients who survived beyond one year, focused on left and right ventricular systolic function, together with cardiac biomarkers evolution, were compared between the two groups. Results: At baseline, there were no significant differences in left ventricular (LV) function parameters, except for a higher Tei Index in the COVID-19 group (p < 0.01). Right ventricular (RV) systolic dysfunction was more frequent in the COVID-19 group, with worse fractional area change (FAC) (p = 0.01), RV free wall longitudinal strain (RVFWLS) (p = 0.01), and RV Tei Index (p = 0.01). Over time, the control group showed a decline in LV ejection fraction (EF), while the COVID-19 group slightly improved. RV global systolic function was better preserved in the COVID-19 group. To the best of our knowledge, this is the first study that demonstrates a statistically significant increase in LAVi in patients with COVID-19. Conclusions: Prior COVID-19 infection influenced the trajectory of LV and RV function in CKD patients over 12 months, suggesting potential transient myocardial adaptations. While overall cardiac function did not differ significantly between groups, COVID-19 survivors exhibited better preservation of some ventricular function parameters.
Keywords: COVID-19; RV systolic function; end stage renal disease; myocardial performance.
. 2025 Mar 8;14(6):1823.
doi: 10.3390/jcm14061823. Long-Term Evolution of Post-COVID-19 Echocardiographic Parameters in Patients with Chronic Kidney Disease: A Prospective Comparative Observational Study
Laura Vasiliu[SUP] 1 2 [/SUP], Anca Diaconu[SUP] 2 [/SUP], Mihai Onofriescu[SUP] 1 [/SUP], Gianina Dodi[SUP] 1 [/SUP], Alexandra Covic[SUP] 1 2 [/SUP], Alexandra E Avanu[SUP] 1 [/SUP], Luminita Voroneanu[SUP] 1 [/SUP], Vlad Vasiliu[SUP] 1 [/SUP], Mehmet Kanbay[SUP] 3 [/SUP], Radu A Sascău[SUP] 1 2 [/SUP], Cristian Stătescu[SUP] 1 2 [/SUP], Adrian C Covic[SUP] 1 4 5 [/SUP]
Affiliations
- PMID: 40142631
- DOI: 10.3390/jcm14061823
Background/Objectives: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused post-acute sequelae, especially for people with pre-existing conditions, including chronic kidney disease (CKD), which may impact the cardiovascular system. Yet, despite the preliminary description of the general population's long-COVID-19 consequences, data on CKD patients is scarce. The aim of this study was to investigate the longitudinal effects of COVID-19 on echocardiographic parameters of cardiac function and on cardiac biomarkers in patients with CKD. Methods: A total of 163 patients were included in this observational prospective trial (listed under NCT05125913 code): 88 in the COVID-19 group and 75 in the control group. The serial echocardiographic characteristics in patients who survived beyond one year, focused on left and right ventricular systolic function, together with cardiac biomarkers evolution, were compared between the two groups. Results: At baseline, there were no significant differences in left ventricular (LV) function parameters, except for a higher Tei Index in the COVID-19 group (p < 0.01). Right ventricular (RV) systolic dysfunction was more frequent in the COVID-19 group, with worse fractional area change (FAC) (p = 0.01), RV free wall longitudinal strain (RVFWLS) (p = 0.01), and RV Tei Index (p = 0.01). Over time, the control group showed a decline in LV ejection fraction (EF), while the COVID-19 group slightly improved. RV global systolic function was better preserved in the COVID-19 group. To the best of our knowledge, this is the first study that demonstrates a statistically significant increase in LAVi in patients with COVID-19. Conclusions: Prior COVID-19 infection influenced the trajectory of LV and RV function in CKD patients over 12 months, suggesting potential transient myocardial adaptations. While overall cardiac function did not differ significantly between groups, COVID-19 survivors exhibited better preservation of some ventricular function parameters.
Keywords: COVID-19; RV systolic function; end stage renal disease; myocardial performance.